159 related articles for article (PubMed ID: 10976519)
1. Triazene drug metabolites. Part 17: Synthesis and plasma hydrolysis of acyloxymethyl carbamate derivatives of antitumour triazenes.
Carvalho E; Francisco AP; Iley J; Rosa E
Bioorg Med Chem; 2000 Jul; 8(7):1719-25. PubMed ID: 10976519
[TBL] [Abstract][Full Text] [Related]
2. Triazene drug metabolites: part 15. Synthesis and plasma hydrolysis of anticancer triazenes containing amino acid carriers.
Carvalho E; Iley J; Perry MJ; Rosa E
Pharm Res; 1998 Jun; 15(6):931-5. PubMed ID: 9647361
[TBL] [Abstract][Full Text] [Related]
3. Towards an efficient prodrug of the alkylating metabolite monomethyltriazene: synthesis and stability of N-acylamino acid derivatives of triazenes.
Perry Mde J; Carvalho E; Rosa E; Iley J
Eur J Med Chem; 2009 Mar; 44(3):1049-56. PubMed ID: 18687506
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of N-acylamino acids derivatives of triazenes. Activation by tyrosinase in human melanoma cell lines.
Monteiro AS; Almeida J; Cabral G; Severino P; Videira PA; Sousa A; Nunes R; Pereira JD; Francisco AP; Perry MJ; Mendes E
Eur J Med Chem; 2013; 70():1-9. PubMed ID: 24125877
[TBL] [Abstract][Full Text] [Related]
5. Triazene metabolism. VI. 3-Azidomethyl-3-alkyl-1-aryltriazenes, a new class of anti-tumour triazene with potential pro-drug applications.
Vaughan K; Nicholas G; Singer RD; Roy M; Gibson NW
Anticancer Drug Des; 1987 Dec; 2(3):279-87. PubMed ID: 3449091
[TBL] [Abstract][Full Text] [Related]
6. Phosphoryloxymethyl carbamates and carbonates--novel water-soluble prodrugs for amines and hindered alcohols.
Safadi M; Oliyai R; Stella VJ
Pharm Res; 1993 Sep; 10(9):1350-5. PubMed ID: 8234176
[TBL] [Abstract][Full Text] [Related]
7. Triazene metabolism. III. In vitro cytotoxicity towards M21 cells and in vivo antitumour activity of the proposed metabolites of the antitumour 1-aryl-3,3-dimethyltriazenes.
Kohlsmith DJ; Vaughan K; Luner SJ
Can J Physiol Pharmacol; 1984 Apr; 62(4):396-402. PubMed ID: 6733585
[TBL] [Abstract][Full Text] [Related]
8. Dopamine- and tyramine-based derivatives of triazenes: activation by tyrosinase and implications for prodrug design.
Perry MJ; Mendes E; Simplício AL; Coelho A; Soares RV; Iley J; Moreira R; Francisco AP
Eur J Med Chem; 2009 Aug; 44(8):3228-34. PubMed ID: 19386398
[TBL] [Abstract][Full Text] [Related]
9. A carbamate-based approach to primaquine prodrugs: antimalarial activity, chemical stability and enzymatic activation.
Mata G; do Rosário VE; Iley J; Constantino L; Moreira R
Bioorg Med Chem; 2012 Jan; 20(2):886-92. PubMed ID: 22189276
[TBL] [Abstract][Full Text] [Related]
10. Carbamate ester prodrugs of dopaminergic compounds: synthesis, stability, and bioconversion.
Hansen KT; Faarup P; Bundgaard H
J Pharm Sci; 1991 Aug; 80(8):793-8. PubMed ID: 1686464
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, chemical and enzymatic hydrolysis, and bioavailability evaluation in rabbits of metronidazole amino acid ester prodrugs with enhanced water solubility.
Mahfouz NM; Hassan MA
J Pharm Pharmacol; 2001 Jun; 53(6):841-8. PubMed ID: 11428660
[TBL] [Abstract][Full Text] [Related]
12. New 3'-azido-3'-deoxythymidin-5'-yl O-(omega-hydroxyalkyl) carbonate prodrugs: synthesis and anti-HIV evaluation.
Vlieghe P; Bihel F; Clerc T; Pannecouque C; Witvrouw M; De Clercq E; Salles JP; Chermann JC; Kraus JL
J Med Chem; 2001 Mar; 44(5):777-86. PubMed ID: 11262088
[TBL] [Abstract][Full Text] [Related]
13. Acyloxymethyl as a drug protecting group: Part 4. The hydrolysis of tertiary amidomethyl ester prodrugs of carboxylic acid agents.
Iley J; Moreira R; Calheiros T; Mendes E
Pharm Res; 1997 Nov; 14(11):1634-9. PubMed ID: 9434286
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of methyltriazene prodrugs simultaneously releasing DNA-methylating agents and the antiresistance drug O(6)-benzylguanine.
Wanner MJ; Koch M; Koomen GJ
J Med Chem; 2004 Dec; 47(27):6875-83. PubMed ID: 15615536
[TBL] [Abstract][Full Text] [Related]
15. Isosorbide-based aspirin prodrugs. II. Hydrolysis kinetics of isosorbide diaspirinate.
Gilmer JF; Moriarty LM; Lally MN; Clancy JM
Eur J Pharm Sci; 2002 Sep; 16(4-5):297-304. PubMed ID: 12208460
[TBL] [Abstract][Full Text] [Related]
16. Development of triazene prodrugs for ADEPT strategy: new insights into drug delivery system based on carboxypeptidase G2 activation.
Capucha V; Mendes E; Francisco AP; Perry MJ
Bioorg Med Chem Lett; 2012 Nov; 22(22):6903-8. PubMed ID: 23041157
[TBL] [Abstract][Full Text] [Related]
17. Effects of structural variations on the rates of enzymatic and nonenzymatic hydrolysis of carbonate and carbamate esters.
Nassar MN; Agha BJ; Digenis GA
J Pharm Sci; 1992 Mar; 81(3):295-8. PubMed ID: 1640371
[TBL] [Abstract][Full Text] [Related]
18. Triazene metabolism. V. Chemical and biological properties of N,N-bis-[(1-aryl-3-methyltriazen-3-yl)-methyl]-methylamines: potential prodrugs for the cytotoxic monomethyltriazenes.
Manning HW; Cameron LM; LaFrance RJ; Vaughan K; Rajaraman R
Anticancer Drug Des; 1985 Oct; 1(1):37-43. PubMed ID: 3870879
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the potency of epidermal growth factor (EGFR)-DNA targeting combi-molecules containing a hydrolabile carbamate at the 3-position of the triazene chain.
MacPhee M; Rachid Z; Todorova M; Qiu Q; Belinsky G; Jean-Claude BJ
Invest New Drugs; 2011 Oct; 29(5):833-45. PubMed ID: 20428924
[TBL] [Abstract][Full Text] [Related]
20. Triazene metabolism. IV. Derivatives of hydroxymethyltriazenes: potential prodrugs for the active metabolites of the anti-tumour triazene, DTIC.
Cameron LM; LaFrance RJ; Hemens CM; Vaughan K; Rajaraman R; Chubb DC; Goddard PM
Anticancer Drug Des; 1985 Oct; 1(1):27-36. PubMed ID: 3870878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
